BioRem Inc. (CVE:BRM – Free Report) – Stock analysts at Cormark lowered their FY2025 earnings per share estimates for shares of BioRem in a research note issued to investors on Tuesday, April 22nd. Cormark analyst N. Boychuk now forecasts that the company will post earnings per share of $0.21 for the year, down from their prior forecast of $0.22. Cormark also issued estimates for BioRem’s FY2026 earnings at $0.27 EPS.
BioRem Stock Performance
CVE:BRM opened at C$1.95 on Wednesday. The company has a market cap of C$31.98 million, a price-to-earnings ratio of 6.02 and a beta of 0.85. BioRem has a fifty-two week low of C$1.84 and a fifty-two week high of C$3.45. The company has a debt-to-equity ratio of 37.47, a quick ratio of 1.08 and a current ratio of 1.91. The stock has a fifty day moving average price of C$2.38 and a 200-day moving average price of C$2.70.
About BioRem
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.
See Also
- Five stocks we like better than BioRem
- Are Penny Stocks a Good Fit for Your Portfolio?
- Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY
- Compound Interest and Why It Matters When Investing
- Fundamentally Sound Verizon Pulls Back Into Buying Opportunity
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Could Palantir’s Latest Partnership Set a Base for a Move Higher?
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
